C H Packman
Overview
Explore the profile of C H Packman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lockhart P, Brennan M, Kent M, Packman C, Norton H, Fox P, et al.
Bone Marrow Transplant
. 2005 Feb;
35(7):713-20.
PMID: 15696181
Pilocarpine hydrochloride has been reported to increase salivation and decrease oral mucositis in patients receiving head and neck radiotherapy, but there is only one report of its use in a...
2.
3.
Rowe J, Rapoport A, Ryan D, Nilsson B, Duerst R, Packman C, et al.
Bone Marrow Transplant
. 1999 Dec;
24(10):1057-63.
PMID: 10578155
Unmanipulated autologous bone marrow transplant (ABMT) offers patients with chronic myelogenous leukemia (CML) a long-term survival of 10%, at best. Immunotherapy has a role in the myeloid leukemias, and there...
4.
Rapoport A, Miller Watelet L, Linder T, Eberly S, Raubertas R, Lipp J, et al.
J Clin Oncol
. 1999 Nov;
17(8):2446-53.
PMID: 10561308
Purpose: To identify predictors of oral mucositis and gastrointestinal toxicity after high-dose therapy. Patients And Methods: Mucositis and gastrointestinal toxicity were prospectively evaluated in 202 recipients of high-dose therapy and...
5.
Lancet J, Rapoport A, Brasacchio R, Eberly S, Raubertas R, Linder T, et al.
Bone Marrow Transplant
. 1998 Aug;
22(3):265-71.
PMID: 9720740
Seventy consecutive patients with refractory or relapsed Hodgkin's disease who received high-dose chemotherapy followed by autologous stem cell rescue were analyzed to identify clinically relevant predictors of long-term event-free survival....
6.
Packman C
Blood Rev
. 1998 May;
12(1):1-11.
PMID: 9597193
Over the past 30 years, our understanding of the pathogenesis of paroxysmal nocturnal haemoglobinuria (PNH) has increased dramatically. During that time, the events during complement activation and regulation have been...
7.
Rapoport A, Constine L, Packman C, Rosier R, OKeefe R, Hicks D, et al.
Am J Hematol
. 1998 May;
58(1):1-7.
PMID: 9590141
Primary bone involvement is an unusual extranodal presentation of non-Hodgkin lymphoma (NHL). The optimal treatment for this entity has not been determined. While solitary bone lymphomas can be eradicated with...
8.
Rapoport A, Lifton R, Constine L, Duerst R, Abboud C, Liesveld J, et al.
Bone Marrow Transplant
. 1997 May;
19(9):883-90.
PMID: 9156261
One hundred and thirty-six patients autografted for relapsed or refractory non-Hodgkin's lymphoma (NHL) were evaluated to assess long-term event-free survival and to identify important prognostic factors. High-dose therapy consisted primarily...
9.
RASHBA E, Rowe J, Packman C
Blood Rev
. 1996 Sep;
10(3):177-84.
PMID: 8932830
This review sets out to synthesize and critically evaluate the current reported data regarding therapeutic options for the neutropenia associated with Felty syndrome (Felty neutropenia). A MEDLINE search and bibliographies...
10.
Hallows K, Law F, Packman C, Knauf P
J Cell Physiol
. 1996 Apr;
167(1):60-71.
PMID: 8698841
Cell volume regulation occurs via the regulated fluxes of ions and solutes across the cell membrane in response to cell volume perturbations under anisotonic conditions. Our earlier studies in human...